MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm – Macrogenics (NASDAQ:MGNX)

By: Alex Freidmen







MacroGenics, Inc. Faces Securities Fraud Lawsuit

Investors Alerted to Securities Fraud Lawsuit against MacroGenics, Inc.

LOS ANGELES, Aug. 28, 2024 — The Schall Law Firm, a national shareholder rights litigation firm, has reminded investors of a class action lawsuit against MacroGenics, Inc. (“MacroGenics” or “the Company”) MGNX for

See also  Unraveling the Baidu Stock Enigma: A Slow and Steady Play on China's Economic Evolution